(Q61810264)

Europe PubMed Central

Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease

31 August 2020

cites work

1 reference

12 December 2020

Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies

1 reference

12 December 2020

Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid

1 reference

12 December 2020

Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies

1 reference

12 December 2020

Effects of pemphigus antibody on the regeneration of cell-cell contact in keratinocyte cultures grown in low to normal Ca++ concentration

1 reference

12 December 2020

Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.

1 reference

12 December 2020

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

1 reference

12 December 2020

The role of complement in experimental bullous pemphigoid.

1 reference

12 December 2020

The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation

1 reference

12 December 2020

The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes

1 reference

12 December 2020

Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain

1 reference

12 December 2020

Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice

1 reference

12 December 2020

Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization

1 reference

12 December 2020

A major role for neutrophils in experimental bullous pemphigoid.

1 reference

12 December 2020

A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid

1 reference

12 December 2020

Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.

1 reference

12 December 2020

IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180

1 reference

12 December 2020

Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model

1 reference

12 December 2020

Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice

1 reference

12 December 2020

The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4.

1 reference

12 December 2020

Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production

1 reference

12 December 2020

Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180

1 reference

12 December 2020

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators

1 reference

12 December 2020

A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.

1 reference

12 December 2020

BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid

1 reference

12 December 2020

Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain

1 reference

12 December 2020

Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3

1 reference

12 December 2020

Mucous membrane pemphigoid and pseudopemphigoid

1 reference

12 December 2020

Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients

1 reference

12 December 2020

Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid

1 reference

12 December 2020

Analysis of Antigens Targeted by Circulating IgG and IgA Antibodies in Patients With Mucous Membrane Pemphigoid Predominantly Affecting the Oral Cavity

1 reference

12 December 2020

In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris

1 reference

12 December 2020

Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity

1 reference

12 December 2020

Antigen specificity in subsets of mucous membrane pemphigoid

1 reference

12 December 2020

Humanization of autoantigen

1 reference

12 December 2020

Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies

1 reference

12 December 2020

Oral mucosal diseases: mucous membrane pemphigoid

1 reference

12 December 2020

IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment

1 reference

12 December 2020

Histopathology of anti-laminin 5 mucous membrane pemphigoid

1 reference

12 December 2020

Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid

1 reference

12 December 2020

A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid

1 reference

12 December 2020

Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida

1 reference

12 December 2020

Urban legend series: mucous membrane pemphigoid

1 reference

12 December 2020

Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing.

1 reference

12 December 2020

A stab-and-roll biopsy technique to maintain gingival epithelium for desquamative gingivitis

1 reference

12 December 2020

Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.

1 reference

12 December 2020

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

1 reference

12 December 2020

Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.

1 reference

12 December 2020

World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid.

1 reference

12 December 2020

Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement.

1 reference

12 December 2020

Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm

1 reference

12 December 2020

Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.

1 reference

12 December 2020

Diagnostic performance of the "MESACUP anti-Skin profile TEST"

1 reference

12 December 2020

Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin.

1 reference

12 December 2020

Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.

1 reference

12 December 2020

Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid

1 reference

12 December 2020

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.

1 reference

12 December 2020

Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.

1 reference

12 December 2020

Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes.

1 reference

12 December 2020

Complement-independent blistering mechanisms in bullous pemphigoid

1 reference

12 December 2020

Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease.

1 reference

12 December 2020

Mechanisms of Autoantibody-Induced Pathology.

1 reference

12 December 2020

Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid

1 reference

12 December 2020

Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay

1 reference

12 December 2020

Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

1 reference

12 December 2020

In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases.

1 reference

12 December 2020

Oral mucosa is a useful substrate for detecting autoantibodies of mucous membrane pemphigoid.

1 reference

12 December 2020

HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors.

1 reference

12 December 2020

Mucous Membrane Pemphigoid with Ocular Involvement: The Clinical Phenotype and Its Relationship to Direct Immunofluorescence Findings.

1 reference

12 December 2020

Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid.

1 reference

12 December 2020

High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa

1 reference

12 December 2020

Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement

1 reference

12 December 2020

Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.

1 reference

12 December 2020

Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation

1 reference

12 December 2020

HLA alleles in British Caucasians with mucous membrane pemphigoid

1 reference

12 December 2020

Immunohistochemical diagnosis of mucous membrane pemphigoid

1 reference

12 December 2020

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

1 reference

12 December 2020

Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid.

1 reference

12 December 2020

The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies

1 reference

12 December 2020

A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid

1 reference

12 December 2020

The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes

1 reference

12 December 2020

Normal human skin is superior to monkey esophagus substrate for detection of circulating BP180-NC16A-specific immunoglobulin G antibodies in bullous pemphigoid

1 reference

12 December 2020